Immunotherapy of colon cancer

Dariusz W. Kowalczyk

eISSN: 1897-4309
ISSN: 1428-2526

Contemporary Oncology/Współczesna Onkologia

Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

3/2006
vol. 10

Send email

Copy url:

abstract:

Immunotherapy of colon cancer

Dariusz W. Kowalczyk

Współcz Onkol (2006) vol. 10; 3 (111-115)

Online publish date: 2006/04/12

View full text Get citation

Despite many difficulties, immunotherapy of colon cancer becomes more effective and slowly enters into everyday clinical practice. The long way from unspecific immune stimulators such as levamisole, BCG, interleukins and interferons ended up in specific anti-cancer vaccines and precise antibody based therapeutics. Nowadays, among novel anticancer agents used in colon cancer therapy there is a place for vaccines such as OncoVax and monoclonals including cetuximab, bevacizumab and panitumumab.

keywords:

Immunotherapy of colon cancer

Dariusz W. Kowalczyk

colon cancer, immunotherapy, vaccines, antibodies